Cite
Editorial: bacterial gut symbionts as live biotherapeutic agents in irritable bowel syndrome-a rosy future despite potential long-term safety concerns.
MLA
Mantegazza, Giacomo, et al. “Editorial: Bacterial Gut Symbionts as Live Biotherapeutic Agents in Irritable Bowel Syndrome-a Rosy Future despite Potential Long-Term Safety Concerns.” Alimentary Pharmacology & Therapeutics, vol. 57, no. 3, Feb. 2023, pp. 345–46. EBSCOhost, https://doi.org/10.1111/apt.17332.
APA
Mantegazza, G., Gargari, G., & Guglielmetti, S. (2023). Editorial: bacterial gut symbionts as live biotherapeutic agents in irritable bowel syndrome-a rosy future despite potential long-term safety concerns. Alimentary Pharmacology & Therapeutics, 57(3), 345–346. https://doi.org/10.1111/apt.17332
Chicago
Mantegazza, Giacomo, Giorgio Gargari, and Simone Guglielmetti. 2023. “Editorial: Bacterial Gut Symbionts as Live Biotherapeutic Agents in Irritable Bowel Syndrome-a Rosy Future despite Potential Long-Term Safety Concerns.” Alimentary Pharmacology & Therapeutics 57 (3): 345–46. doi:10.1111/apt.17332.